Discovery Scientist – Immunology

argenx SE in Gent/Zwijnaarde seeks a Principal Scientist to oversee parts of the discovery pipeline, guiding multiple project teams, setting priorities, and addressing biology risks early in drug development. You will shape the longer-term scientific direction, evaluate new opportunities, and coach junior scientists to build the next generation of leaders...

argenx is seeking a Scientist to join our dynamic R&D team in Gent/Zwijnaarde. The candidate should drive hands-on lab work and take scientific ownership of defined discovery projects, coordinating research activities with the project team.This role operates in a fast-growing biotech environment with a focus on novel therapeutics for autoimmune diseases. The...

argenx SE is seeking a Principal Scientist to lead biology-driven discovery efforts in Gent/Zwijnaarde. You will oversee portions of the discovery pipeline, guiding disease- and target-biology questions and shaping project workplans with a focus on early risk assessment and translational potential.You will develop future leaders, coach teams, and engage...

Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to...

Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to...

Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to...

Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to...

Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to...

Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to...